Evidence map›Paper›PMID 18573323›Full record

ArticleHearing research2008

Localized cell and drug delivery for auditory prostheses.

Jeffrey L Hendricks, Jennifer A Chikar, Mark A Crumling, Yehoash Raphael, David C Martin

Abstract read
In one paragraph

Article in Hearing research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 69 citations in OpenAlex.

  1. Electrode impedance in cochlear implantation: determinants, dynamics, and clinical implications.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Review
  2. Angular Insertion Depth for Cochlear Implantation: A Comparative Analysis on Precision of CT, MRI, and x-Ray.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Local Drug Delivery for the Treatment of Neurotology Disorders.Frontiers in cellular neuroscience · 2019
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Bioelectronic neural pixel: Chemical stimulation and electrical sensing at the same site.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jeffrey L HendricksDepartment of Biomedical Engineering, The University of Michigan, 1107 Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109-2099, USA. jlhendri@umich.edu
Jennifer A Chikar
Mark A Crumling
Yehoash Raphael
David C Martin
University of Michigan–Ann Arbor · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHACHT, JOCHEN · 2002 to 2016
$10.3M
Early Stage Training in the NeurosciencesT32NS076401 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Carol Fuzeti Elias, LESLIE S. SATIN · 2011 to 2026
$3.1M
SCAR FORMATION IN DAMAGED AND REGENERATING COCHLEAER01DC001634 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 1993 to 2009
$2.4M
GDNF Protection in the Inner EarR01DC005401 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 2002 to 2005
$933k
Improved efficacy of cochlear implants by directed regrowth of the auditory nerveF31DC009134 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHIKAR, JENNIFER A · 2007 to 2007
$34k
NIDCD NIH HHS F31 DC009134NIDCD NIH HHS F31-DC009134NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30-DC05188NIDCD NIH HHS R01 DC001634NIDCD NIH HHS R01 DC005401NIDCD NIH HHS R01-DC01634NIDCD NIH HHS R01-DC05401NINDS NIH HHS T32 NS076401
6 · The paper itself

Abstract

Localized cell and drug delivery to the cochlea and central auditory pathway can improve the safety and performance of implanted auditory prostheses (APs). While generally successful, these devices have a number of limitations and adverse effects including limited tonal and dynamic ranges, channel interactions, unwanted stimulation of non-auditory nerves, immune rejection, and infections including meningitis. Many of these limitations are associated with the tissue reactions to implanted auditory prosthetic devices and the gradual degeneration of the auditory system following deafness. Strategies to reduce the insertion trauma, degeneration of target neurons, fibrous and bony tissue encapsulation, and immune activation can improve the viability of tissue required for AP function as well as improve the resolution of stimulation for reduced channel interaction and improved place-pitch and level discrimination. Many pharmaceutical compounds have been identified that promote the viability of auditory tissue and prevent inflammation and infection. Cell delivery and gene therapy have provided promising results for treating hearing loss and reversing degeneration. Currently, many clinical and experimental methods can produce extremely localized and sustained drug delivery to address AP limitations. These methods provide better control over drug concentrations while eliminating the adverse effects of systemic delivery. Many of these drug delivery techniques can be integrated into modern auditory prosthetic devices to optimize the tissue response to the implanted device and reduce the risk of infection or rejection. Together, these methods and pharmaceutical agents can be used to optimize the tissue-device interface for improved AP safety and effectiveness.

Indexed as

Infusion Pumps, ImplantableAnimalsAuditory PathwaysCatsCell TransplantationCochleaCochlear ImplantsDeafnessGenetic TherapyGuinea PigsHumansModels, AnimalNerve Growth FactorsNerve Growth Factors

Identifiers

PMID18573323
PMCPMC3073348
OpenAlexW1989356847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.